These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

332 related items for PubMed ID: 17592251

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. CD133 and CD44 are universally overexpressed in GIST and do not represent cancer stem cell markers.
    Chen J, Guo T, Zhang L, Qin LX, Singer S, Maki RG, Taguchi T, Dematteo R, Besmer P, Antonescu CR.
    Genes Chromosomes Cancer; 2012 Feb; 51(2):186-95. PubMed ID: 22076958
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Cells with characteristics of cancer stem/progenitor cells express the CD133 antigen in human endometrial tumors.
    Rutella S, Bonanno G, Procoli A, Mariotti A, Corallo M, Prisco MG, Eramo A, Napoletano C, Gallo D, Perillo A, Nuti M, Pierelli L, Testa U, Scambia G, Ferrandina G.
    Clin Cancer Res; 2009 Jul 01; 15(13):4299-311. PubMed ID: 19509143
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Human α(2)β(1)(HI) CD133(+VE) epithelial prostate stem cells express low levels of active androgen receptor.
    Williamson SC, Hepburn AC, Wilson L, Coffey K, Ryan-Munden CA, Pal D, Leung HY, Robson CN, Heer R.
    PLoS One; 2012 Jul 01; 7(11):e48944. PubMed ID: 23145034
    [Abstract] [Full Text] [Related]

  • 12. Expression of aldehyde dehydrogenase and CD133 defines ovarian cancer stem cells.
    Kryczek I, Liu S, Roh M, Vatan L, Szeliga W, Wei S, Banerjee M, Mao Y, Kotarski J, Wicha MS, Liu R, Zou W.
    Int J Cancer; 2012 Jan 01; 130(1):29-39. PubMed ID: 21480217
    [Abstract] [Full Text] [Related]

  • 13. CD133 and CD44 cell surface markers do not identify cancer stem cells in primary human gastric tumors.
    Rocco A, Liguori E, Pirozzi G, Tirino V, Compare D, Franco R, Tatangelo F, Palaia R, D'Armiento FP, Pollastrone G, Affuso A, Bottazzi EC, Masone S, Persico G, Nardone G.
    J Cell Physiol; 2012 Jun 01; 227(6):2686-93. PubMed ID: 21898409
    [Abstract] [Full Text] [Related]

  • 14. CD49f-positive cell population efficiently enriches colon cancer-initiating cells.
    Haraguchi N, Ishii H, Mimori K, Ohta K, Uemura M, Nishimura J, Hata T, Takemasa I, Mizushima T, Yamamoto H, Doki Y, Mori M.
    Int J Oncol; 2013 Aug 01; 43(2):425-30. PubMed ID: 23708747
    [Abstract] [Full Text] [Related]

  • 15. Isolation, characterization and mobilization of prostate cancer tissue derived CD133+ MDR1+ cells.
    Rentala S, Mangamoori LN.
    J Stem Cells; 2010 Aug 01; 5(2):75-81. PubMed ID: 22049617
    [Abstract] [Full Text] [Related]

  • 16. ALDH activity selectively defines an enhanced tumor-initiating cell population relative to CD133 expression in human pancreatic adenocarcinoma.
    Kim MP, Fleming JB, Wang H, Abbruzzese JL, Choi W, Kopetz S, McConkey DJ, Evans DB, Gallick GE.
    PLoS One; 2011 Aug 01; 6(6):e20636. PubMed ID: 21695188
    [Abstract] [Full Text] [Related]

  • 17. Phenotypic subpopulations of metastatic colon cancer stem cells: genomic analysis.
    Botchkina IL, Rowehl RA, Rivadeneira DE, Karpeh MS, Crawford H, Dufour A, Ju J, Wang Y, Leyfman Y, Botchkina GI.
    Cancer Genomics Proteomics; 2009 Aug 01; 6(1):19-29. PubMed ID: 19451087
    [Abstract] [Full Text] [Related]

  • 18. The role of CD133 in the identification and characterisation of tumour-initiating cells in non-small-cell lung cancer.
    Tirino V, Camerlingo R, Franco R, Malanga D, La Rocca A, Viglietto G, Rocco G, Pirozzi G.
    Eur J Cardiothorac Surg; 2009 Sep 01; 36(3):446-53. PubMed ID: 19464919
    [Abstract] [Full Text] [Related]

  • 19. Prolonged drug selection of breast cancer cells and enrichment of cancer stem cell characteristics.
    Calcagno AM, Salcido CD, Gillet JP, Wu CP, Fostel JM, Mumau MD, Gottesman MM, Varticovski L, Ambudkar SV.
    J Natl Cancer Inst; 2010 Nov 03; 102(21):1637-52. PubMed ID: 20935265
    [Abstract] [Full Text] [Related]

  • 20. CD133+, CD166+CD44+, and CD24+CD44+ phenotypes fail to reliably identify cell populations with cancer stem cell functional features in established human colorectal cancer cell lines.
    Muraro MG, Mele V, Däster S, Han J, Heberer M, Cesare Spagnoli G, Iezzi G.
    Stem Cells Transl Med; 2012 Aug 03; 1(8):592-603. PubMed ID: 23197865
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.